mebendazole has been researched along with Diabetes Mellitus, Type 1 in 3 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After the observation of decreasing insulin resistance in a diabetic patient during treatment with mebendazole for nematosis, we investigated the effect of mebendazole on metabolic control in six Type 1 (insulin-dependent) and six Type 2 (non-insulin-dependent) diabetic patients, eight of whom were chronically resistant to conventional treatment." | 3.67 | Improvement of metabolic control in diabetic patients during mebendazole administration: preliminary studies. ( Boden, G; Caprio, S; Dayal, VK; Hoeldtke, RD; Mozzoli, MA; Owen, OE; Ray, TK; Reichard, GA; Shuman, CR; Smith, RH, 1984) |
| "Based on a population-based analysis, enterobiasis does not reduce risk for asthma, type 1 diabetes, arthritis, or inflammatory bowel disease." | 1.38 | Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study. ( Bager, P; Melbye, M; Vinkel Hansen, A; Wohlfahrt, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bager, P | 1 |
| Vinkel Hansen, A | 1 |
| Wohlfahrt, J | 1 |
| Melbye, M | 1 |
| Caprio, S | 1 |
| Ray, TK | 1 |
| Boden, G | 1 |
| Reichard, GA | 1 |
| Shuman, CR | 1 |
| Smith, RH | 1 |
| Mozzoli, MA | 1 |
| Dayal, VK | 1 |
| Hoeldtke, RD | 1 |
| Owen, OE | 1 |
| Van Gaal, LF | 1 |
| De Leeuw, IH | 1 |
3 other studies available for mebendazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study.
Topics: Adolescent; Animals; Antinematodal Agents; Arthritis, Juvenile; Asthma; Child; Child, Preschool; Coh | 2012 |
Improvement of metabolic control in diabetic patients during mebendazole administration: preliminary studies.
Topics: Adult; Benzimidazoles; Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 1; Diabetes | 1984 |
Influence of mebendazole administration on metabolic control in type 1 (insulin-dependent) diabetic patients.
Topics: Benzimidazoles; Blood Glucose; Diabetes Mellitus, Type 1; Humans; Mebendazole; Middle Aged | 1985 |